| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Vicky Cameron | Q30303199 |
| Leigh Ellmers | Q109577755 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2191-2194 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Minireview: natriuretic peptides during development of the fetal heart and circulation | |
| P478 | volume | 144 |
| Q28235995 | A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse |
| Q48176661 | Analytical and clinical performance of three natriuretic peptide tests in the emergency room |
| Q36219423 | Assessing cardiovascular risk in children with chronic kidney disease. B-type natriuretic peptide: a potential new marker |
| Q42521019 | Atrial natriuretic peptide gene - a potential biomarker for long QT syndrome. |
| Q41511312 | Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis |
| Q98177450 | BNP as a New Biomarker of Cardiac Thyroid Hormone Function |
| Q33573360 | Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent |
| Q48435084 | Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth. |
| Q34744358 | Cardiorenal syndrome is present in human fetuses with severe, isolated urinary tract malformations |
| Q34252233 | Circulating N-terminal pro-B-type natriuretic peptide in fetal anemia before and after treatment |
| Q42038020 | Clinical perspectives of urocortin and related agents for the treatment of cardiovascular disease |
| Q51869600 | Computational modeling for the optimization of a cardiogenic 3D bioprocess of encapsulated embryonic stem cells. |
| Q37095850 | Culture on electrospun polyurethane scaffolds decreases atrial natriuretic peptide expression by cardiomyocytes in vitro |
| Q30559093 | Design and formulation of functional pluripotent stem cell-derived cardiac microtissues |
| Q48458807 | Effects of a long-distance run on cardiac markers in healthy athletes |
| Q92817868 | Endothelial cell modulation of cardiomyocyte gene expression |
| Q44930254 | Epigenetic control of cardiomyocyte production in response to a stress during the medaka heart development |
| Q52046408 | Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. |
| Q37193692 | Fetal development of regulatory mechanisms for body fluid homeostasis |
| Q39831438 | Forward programming of pluripotent stem cells towards distinct cardiovascular cell types |
| Q27334821 | Functional modulation of cardiac form through regionally confined cell shape changes |
| Q44440207 | Glucocorticoid receptor is required for foetal heart maturation |
| Q55039464 | Glucocorticoids, antenatal corticosteroid therapy and fetal heart maturation. |
| Q82505537 | Hyperthermia induced atrial natriuretic peptide expression and deviant heart development in Atlantic salmon Salmo salar embryos |
| Q41690530 | IGF1 and NRG1 Enhance Proliferation, Metabolic Maturity, and the Force-Frequency Response in hESC-Derived Engineered Cardiac Tissues |
| Q37379787 | Maternal high-salt intake during pregnancy reprogrammed renin-angiotensin system-mediated cardiomyocyte apoptosis in the adult offspring heart |
| Q36525043 | Membrane guanylyl cyclase receptors: an update |
| Q48871174 | N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations. |
| Q43968441 | Old tool - new application: NT-proBNP in fetal medicine |
| Q44237599 | Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies |
| Q26765883 | Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide? |
| Q36148742 | Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus |
| Q30604339 | Prion protein- and cardiac troponin T-marked interstitial cells from the adult myocardium spontaneously develop into beating cardiomyocytes. |
| Q24322741 | RE1-silencing transcription factor (REST) and REST-interacting LIM domain protein (RILP) affect P19CL6 differentiation |
| Q33867517 | Self-beating atypically shaped cardiomyocytes survive a long-term postnatal development while preserving the expression of fetal cardiac genes in mice |
| Q38537491 | Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review |
| Q51623809 | Systemic, but not cardiomyocyte-specific, deletion of the natriuretic peptide receptor guanylyl cyclase A increases cardiomyocyte number in neonatal mice. |
| Q42706282 | TCDD‑induced chick cardiotoxicity is abolished by a selective cyclooxygenase‑2 (COX‑2) inhibitor NS398. |
| Q50776651 | The MLC1v gene provides a transgenic marker of myocardium formation within developing chambers of the Xenopus heart. |
| Q37976652 | The interactome of LIM domain proteins: the contributions of LIM domain proteins to heart failure and heart development |
| Q36188897 | Transcriptome Dynamics and Potential Roles of Sox6 in the Postnatal Heart. |
| Q48147486 | Troponin T and NT ProBNP Levels in Gestational, Type 1 and Type 2 Diabetic Mothers and Macrosomic Infants. |
| Q37400918 | Troponin T and pro-B-type natriuretic Peptide in fetuses of type 1 diabetic mothers |
| Q34415888 | p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes |
Search more.